Sec-2_Unit-4 Flashcards
TB intro
In 2023, 25L TB patients in Ind(27% of global tb cases)—India TB report 2024
TB treatment(Drugs,vaccine)
Rifampin, Ethambutol
BCG vaccine
Procurement challenge of DR-TB medications like
Delamanid
Bedaquiline
TB vaccine for adults
Spanish vaccine MTBVAC (Bharatbiotech conducting clinical trials of it in Ind)
TB conclusion(2)
SDG-3.3: End TB by 2030
World TB day 2024 theme:”Yes! We can end TB”
Malaria intro
In 2022, Ind accounted for 66% of malaria cases in WHO SE Asia region
Initiatives to tackle malaria(Ind(1), World(2))
National Malaria Control Prog
Global Malaria Prog(WHO)
E-2025
Malarial vaccines(2)
Mosquirix
R21/Matrix-M
2/5 plasmodium parasites pose most malaria threat
P. Falciparum
P. Vivax
Hepatitis intro
11.6% viral hepatitis disease burden(2nd after China)–Global Hepatitis Report 2024(WHO)
Hep-B,C most common(stat, cause which diseases)
- 1.3mn deaths due to viral hep in 2022. 83% by Hep-B, 17% by Hep-C(Global Hep Report 2024)
- Liver cirrhosis, Liver cancer
Non-viral Hep(2)
ALD
NAFLD
Cervical cancer intro
2nd most common cancer among women in Ind, 1.27L cases & 80k deaths annually(Lancet)
Lethal HPV types
HPV types 16 & 18->70% of all cervical cancer cases globally
Indigenous hpv vaccine
CERVAVAC